Philip Herman
Corporate Officer/Principal bij REPARE THERAPEUTICS INC.
Vermogen: 12 361 $ op 30-04-2024
Profiel
Philip Karl Herman is currently the Executive VP-Commercial & New Product Development at Repare Therapeutics, Inc. He previously worked as the Marketing Director at Vanda Pharmaceuticals, Inc. and as the Vice President, Head-Commercial & Marketing at Dyax Corp.
From 2018 to 2021, he served as the Chief Commercial Officer & Senior Vice President at Y-mAbs Therapeutics, Inc. Mr. Herman holds an MBA degree from Kellogg School of Management and an undergraduate degree from Baldwin Wallace University School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
REPARE THERAPEUTICS INC.
0.01% | 01-04-2024 | 3 924 ( 0.01% ) | 12 361 $ | 30-04-2024 |
Actieve functies van Philip Herman
| Bedrijven | Functie | Begin |
|---|---|---|
| REPARE THERAPEUTICS INC. | Corporate Officer/Principal | 05-01-2022 |
Eerdere bekende functies van Philip Herman
| Bedrijven | Functie | Einde |
|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Corporate Officer/Principal | 31-12-2021 |
| VANDA PHARMACEUTICALS INC. | Verkoop & Marketing | - |
| DYAX CORP. | Verkoop & Marketing | - |
Opleiding van Philip Herman
| Kellogg School of Management | Masters Business Admin |
| Baldwin Wallace University School of Business | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| Y-MABS THERAPEUTICS, INC. | Health Technology |
| REPARE THERAPEUTICS INC. | Health Technology |
| VANDA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Dyax Corp.
 Dyax Corp. Pharmaceuticals: MajorHealth Technology Dyax Corp. engages in discovery, development and commercialization of novel biotherapeutics. The company was founded by Henry E. Blair in 1989 and is headquartered in Burlington, MA. | Health Technology |